BACKGROUND: There are limited data on the epidemiology of paediatric healthcare-associated infection (HCAI) and infection control in low-income countries. We describe the value of intermittent point-prevalence surveys for monitoring HCAI and evaluating infection control interventions in a Cambodian paediatric hospital. METHODS: Hospital-wide, point-prevalence surveys were performed monthly in 2011. Infection control interventions introduced during this period included a hand hygiene programme and a ventilator-associated pneumonia (VAP) care bundle. RESULTS: Overall HCAI prevalence was 13.8/100 patients at-risk, with a significant decline over time. The highest HCAI rates (50%) were observed in critical care; the majority of HCAIs were respi...
Q1Artículo original399-406Objectives: We report the results of the International Nosocomial Infect...
Background: There is a paucity of data describing hospital-acquired infections (HAIs) in Africa. Obj...
Background Antimicrobial use (AMU) is a key driver of antimicrobial resistance (AMR). There are few ...
Background: Healthcare associated infections (HAI) are the most common preventable adverse events fo...
Summary: Barriers to the implementation of the Centers for Disease Control and Prevention (CDC) guid...
There is scarce information regarding hospital-acquired infections (HAIs) among children in resource...
International audienceBACKGROUND: Viruses are detected in most hospitalized children admitted for ac...
Background: Healthcare-associated infections (HAIs) and antimicrobial use (AMU) are important driver...
To determine trends, mortality rates, and costs of antimicrobial resistance in invasive bacterial in...
To determine trends, mortality rates, and costs of antimicrobial resistance in invasive bacterial in...
To determine trends, mortality rates, and costs of antimicrobial resistance in invasive bacterial in...
BACKGROUND: Healthcare-associated infections (HAIs) and antimicrobial use (AMU) are important driver...
OBJECTIVE: Antibiotic resistance is a prominent public and global health concern. We investigated an...
BACKGROUND: Pediatric bacterial bloodstream infections (BSIs) are a major cause of morbidity and mor...
There is scarce information regarding hospital-acquired infections (HAIs) among children in resource...
Q1Artículo original399-406Objectives: We report the results of the International Nosocomial Infect...
Background: There is a paucity of data describing hospital-acquired infections (HAIs) in Africa. Obj...
Background Antimicrobial use (AMU) is a key driver of antimicrobial resistance (AMR). There are few ...
Background: Healthcare associated infections (HAI) are the most common preventable adverse events fo...
Summary: Barriers to the implementation of the Centers for Disease Control and Prevention (CDC) guid...
There is scarce information regarding hospital-acquired infections (HAIs) among children in resource...
International audienceBACKGROUND: Viruses are detected in most hospitalized children admitted for ac...
Background: Healthcare-associated infections (HAIs) and antimicrobial use (AMU) are important driver...
To determine trends, mortality rates, and costs of antimicrobial resistance in invasive bacterial in...
To determine trends, mortality rates, and costs of antimicrobial resistance in invasive bacterial in...
To determine trends, mortality rates, and costs of antimicrobial resistance in invasive bacterial in...
BACKGROUND: Healthcare-associated infections (HAIs) and antimicrobial use (AMU) are important driver...
OBJECTIVE: Antibiotic resistance is a prominent public and global health concern. We investigated an...
BACKGROUND: Pediatric bacterial bloodstream infections (BSIs) are a major cause of morbidity and mor...
There is scarce information regarding hospital-acquired infections (HAIs) among children in resource...
Q1Artículo original399-406Objectives: We report the results of the International Nosocomial Infect...
Background: There is a paucity of data describing hospital-acquired infections (HAIs) in Africa. Obj...
Background Antimicrobial use (AMU) is a key driver of antimicrobial resistance (AMR). There are few ...